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Abstract
In this study, hollow mesoporous silica nanoparticles (HMSNs) were synthesized using the sol-gel/emulsion
approach and its potential application in drug delivery was assessed. The HMSNs were characterized, by
transmission electron microscopy (TEM), Scanning Electron Microscopy (SEM), nitrogen adsorption/desorption and
Brunauer-Emmett-Teller (BET), to have a mesoporous layer on its surface, with an average pore diameter of about 2
nm and a surface area of 880 m
2/g. Fluorescein isothiocyanate (FITC) loaded into these HMSNs was used as a
model platform to assess its efficacy as a drug delivery tool. Its release kinetic study revealed a sequential release of
FITC from the HMSNs for over a period of one week when soaked in inorganic solution, while a burst release
kinetic of the dye was observed just within a few hours of soaking in organic solution. These FITC-loaded HMSNs
was also found capable to be internalized by live human cervical cancer cells (HeLa), wherein it was quickly
released into the cytoplasm within a short period of time after intracellular uptake. We envision that these HMSNs,
with large pores and high efficacy to adsorb chemicals such as the fluorescent dye FITC, could serve as a delivery
vehicle for controlled release of chemicals administered into live cells, opening potential to a diverse range of
applications including drug storage and release as well as metabolic manipulation of cells.
1. Background
For many years, silica has been employed as a versatile
and relatively benign material in material sciences and
engineering due to the variety of available chemical and
physical modifications that it offers as well as the bio-
compatibility feature that it display. It is thus not sur-
prising that silica nanoparticles have recently emerged
as an attractive and widely used chemical/drug delivery
vehicle for basic research and clinical trials. In fact,
amongst these carriers made of silica, hollow spherical
silica nanoparticles with mesoporous walls stands out as
a class of nanomaterials with many distinctive advan-
tages, such as having a non-toxic nature, good surface
permeability, large specific surface area, tunable pore
structures, excellent physicochemical stability and
chemically modifiable surfaces, all of which allow them
to be potential hosts for various chemical agents/
therapeutic drugs. These hollow mesoporous silica
nanoparticles (HMSNs) are especially useful when used
to host therapeutic compounds such as enzymes that
are easily degraded in the hostile biological environment
when delivered per se without encapsulation. Besides
encapsulation, these therapeutic agents can also be cova-
lently attached, or adsorbed onto such silica nanocar-
riers that has been pre-surface modified. Indeed, these
approaches can easily overcome drug solubility and sta-
bility issues, besides having control over the rate in
which the drugs are released. Thus, wide attention has
been placed on the recent application of HMSNs in the
field of biomedicine, including its use as novel materials
in catalysis, separation, cell-labeling and capsule agent
for drug delivery [1,2].
To date, a number of approaches have been employed
to fabricate oxide and sulfide hollow spheres [3,4].
Deposition of silica layer on latex or colloid templates
and subsequent removal of the hard templates by calci-
nation or corrosion has been known to be the conven-
tional approach for preparation of HMSNs [5-7]. Sol-
gel/emulsion method, in which the emulsion droplets
are thermodynamically stable and uniform and act as
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any medium, provided the original work is properly cited.templates for the growth of silica, has also been devel-
oped as an alternative method for the preparation of
HMSNs [8-13]. The formation of hollow silica spheres
by a soft templating scheme depends on the stability of
the surfactant organization, and interfacial deposition
of silica to form the nanoshell. In recent years, a variety
of emulsion systems, such as water-in-oil [14], oil-in-
water [15-18], water-oil-water [19], oil-water-oil [20],
and supercritical CO2-in-water [21,22] have all been
adopted for the preparation of HMSNs. However, uni-
formity of the size and shell thickness of the hollow
silica spheres prepared by the emulsion method are less
satisfactory than those obtained from the hard template
method due to the dynamic character of the emulsion
droplets [23-25]. It was speculated that for oil-in-water
emulsion system, introduction of another solvent that
has good compatibility with both water and TEOS, for
instance ethanol, might be helpful in improving stability
of the oil droplets and thus monodispersity of the
resulting hollow silica spheres.
In this work, we looked into the potential biomedical
applications of HMSNs prepared by a sol-gel/emulsion
(oil-in-water/ethanol) method. The use of ethanol is to
improve the stability of the oil droplets, thus allowing
the preparation of hollow silica spheres with improved
size distribution. Here, the fluorescent dye FITC was
chosen as a model cargo of the HMSNs for easy visuali-
zation of its release behaviour from the nanomaterial
both in different solutions as well as upon uptake by
cells. The possibility of combining both bioactivity and
chemical agent release behaviour can make these
HMSNs as an ideal tool for use in drug delivery
application.
2. Results and Discussions
2.1 Materials characterization
Figure 1 shows representative TEM (Figure 1a and 1c)
and SEM (Figure 1b) images of the silica spheres pre-
pared under a certain ethanol-to-water ratios and 5 mM
CTAB concentration. These images revealed that the
spheres retained their intact spherical nature even after
calcination at 600°C for 6 h. The spheres appear hollow
in character and have an average diameter of about 200
nm. Importantly, Figure 1c also revealed that the shell
display a mesoporous structure that is ordered in the
short range and have a shell thickness of about 20 nm.
Additionally, as these particles were dispersed in water
prior to their observation under electron microscopy,
the images captured also demonstrated that the nano-
particles were well dispersed in water, thus providing
maximal interface to carry optimal amount of chemical
agent for delivery.
The BET surface area of these HMSNs revealed a rela-
tively high value of 880 m
2/ ga ss h o w ni nF i g u r e2 a ,
thus presenting these nanoparticles as an ideal material
for hosting guest molecules of various sizes, shapes and
functionalities. Their pore size distribution as depicted
in Figure 2b showed a wide distribution, with a sharp
peak observed at around 2 nm, thus suggesting a meso-
porous reactive layer formation at the particle surface.
Indeed, formation of these mesoporous structures are
highly favoured as they have a high surface area and
large pore, which allow chemical agents to be hosted
within them in the nanoscale porosity, thereby enhan-
cing the capacity for drug adsorption.
2.2. FITC loading study
The kinetics of FITC adsorption on HMSNs is as shown
in Figure 3. FITC dye dissolved in acetone at a concen-
tration of 1 mg/mL was mixed with HMSNs at different
concentration for several days in order to observe the
relationship between time and concentration of parti-
cles. The data seemed to suggest that there is a two-step
loading pattern observe with all nanoparticle concentra-
tion, with a rapid absorbance of the dye attained in the
first 24 h and a second relatively slow loading phase
occurring in the subsequent two days. It demonstrated
the absorbance of FITC to mesoporous silica nanoparti-
cles is correlative to time point in 24 h. The equilibrium
capacity at 24 h was 19.95, 54.68 and 60.97 μgo fF I T C
per mg of nanoparticles for 1, 5 and 10 mg/mL of
HMSNs, respectively. This indicates that the binding of
FITC is dependent on the concentration of HMSNs, as
seen by the higher adsorption amount of FITC onto the
HMSNs at nanoparticle concentrations of 5 and 10 mg/
mL than at 1 mg/mL, altogether suggesting that the
encapsulation of FITC is a diffusion-driven process.
Taking this result into consideration, we have chosen 5
mg/mL of nanoparticles as the concentration that
is optimal for loading of FITC in all subsequent
experiments.
2.3. FITC release study
The release studies of FITC from HMSNs (5 mg/mL) at
room temperature were conducted either in inorganic
solution such as PBS (pH5.2), RPMI 1640(pH7.4) or
organic solution such as acetone. RPMI 1640 (pH7.4)
was used to assess whether fluorescent dye could be
released from HMSNs before their entry into cell. A pH
value of 5.2 was chosen to mimic the physiological pH
values inside endosomes. Figure 4 shows the cumulative
release kinetics of FITC from HMSNs. The release rate
of FITC from HMSNs in acetone was very rapid, show-
ing a two-step release pattern with a rapid initial burst
release and a subsequent relatively slower sustained
release over five days. The initial burst observed in the
first 6 h released around 70% of the dye, thereafter
remaining almost constant throughout the next five
Guo et al. Chemistry Central Journal 2011, 5:1
http://journal.chemistrycentral.com/content/5/1/1
Page 2 of 10days. Indeed, this is consistent with the low solubility of
FITC in acetone. However, different dye release kinetics
was observed from FITC-loaded HMSNs soaked in PBS
(pH5.2) and cell culture medium. Initial burst released
only around 33.9 and 32.6% of the dye from HMSNs
soaked in PBS (pH5.2) and RPMI 1640 medium, respec-
tively. Following this, FITC was observed to be gradually
released from particles soaked in these two liquids. At
the end of five days, the cumulative amount of released
FITC reached a value of 68.2 and 55.6% in PBS (pH5.2)
and cell culture medium, respectively. Indeed, these
were lower than that released in acetone and thus could
suggest that FITC slow release from the HMSNs in cell
culture medium would reduce its loss from the porous
particles before the latter’s entry into cells. Meanwhile,
this also implies that the use of HMSNs as a drug
carrier could ensure that the drug cargo is released into
the cytoplasm in a slow fashion, thus appropriate for a
sustained drug effect. Furthermore, recent reports on
the design of functional mesoporous silica materials that
have their pore surface decorated with organic or inor-
ganic moieties to serve as gating devices that can regu-
late the release of guest molecules under the control of
several different external stimuli, such as chemicals
[26-29], temperature [30], redox reactions [31,32], and
photoirradiation [33,34], have highlighted the potential
of utilizing such kind of nanodevice for diverse con-
trolled release applications. Indeed, this could be incor-
porated in our future work for controlled release of our
HMSNs by utilizing such different moieties.
Figure 1 TEM (a) and SEM (b) images of HMSNs. TEM image of the shell of a HMSNs at high magnification is shown in (c).
Figure 2 N2 adsorption/desorption isotherms (a) and BET pore size distribution plots (b) of the calcined HMSNs by a sol-gel/emulsion
method.
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Non-Radioactive Cell Proliferation Assay [(3-(4,5-
dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetra zolium, inner sath; MTS) was
used to determine the proliferation and viability of cells
that has been treated with different concentrations of
the nanoparticles. Figure 5 shows the densities of cells
cultured with different concentrations of HMSNs for 24
and 48 h. Even though cell viability was observed to
decrease as a function of concentration and time, it was
noted that none of the cell samples reached below 70%
of viability. As such, this indicates that even at a high
concentration of 2000 μg/mL, the nanoparticles exert no
significant cytotoxic effect on the cells and thus presents
as a safe and ideal delivery vehicle or chemical/drugs
into cells.
2.5 Imaging of FITC-HMSNs labelled cells
The uptake of FITC- mesoporous silica nanoparticles by
HeLa cells was confirmed by confocal fluorescence
microscopy. FITC-loaded HMSNs were passively loaded
into Hela cells by incubating them with 100 μg/mL of
the nanoparticles. Figure 6 shows that the HMSNs were
endocytosed into cells as early as 3 h after exposure
to the nanoparticles and a progressive increase in
fluorescence emitted by nanoparticle-labelled cells was
observed with increased in time point. The fact that
nanoparticles uptake by Hela cells was significantly
higher at 6 h as compared to 3 h of incubation high-
lights the time-dependent accumulation of these nano-
particles within the cells. Recently, it was demonstrated
that particle size determines the mechanism and rate of
intracellular uptake as well as ability of the particle to
permeate through tissue [35,36]. Indeed, the size of a
particle can affect the efficiency and pathway of its cel-
lular uptake by influencing their adhesion and interac-
tion with cells [37]. For biomedical applications, the
control of pore size, morphology, and particle size of
ordered mesoporous silica is thus important. Compared
to bulky mesoporous silica materials, which have sizes
above a micrometer, nanometer-sized mesoporous silica
particles (30 to 500 nm) are better transporters since
they have a fast mass transport, effective adhesion to
substrates, and good suspension in solution. In this
report, the size of mesoporous silica nanoparticles
of about 200 nm in diameter, is therefore ideal for cellu-
lar uptake. It is expected that the size effect on cell
uptake would lead to size-dependent biochemical
Figure 3 Kinetics study of FITC adsorption on HMSNs at different nanoparticle concentration. Insert displays a photograph of HMSNs
before (white color) and after (yellow color) soaking in FITC-acetone solution.
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however, needs further in depth study.
2.6 Endosomeal release of FITC-loaded HMSNs
To determine whether the FITC-loaded HMSNs could
escape the endosomal entrapment, we stained the endo-
somes with a red fluorescent antibody and monitored
the distribution of FITC loaded HMSNs in HeLa cells
by confocal fluorescence micrographs. The yellow fluor-
escent spots (indicative of a merged between the red
and green spots) observed in Figure 7 represent the
FITC-loaded HMSNs that has remained trapped in
endosomes, while those that were released from the
endosomes exhibited a green color. This clearly shows
that the FITC-HMSNs could escape the endosomal
compartment efficiently within a few hours of endocyto-
sis. Interestingly, several red spots with no overlapping
fluorescence from the green FITC-HMSNs were also
observed in the cell. This could either be endosomes
that have not harbour any FITC-mesoporous silica
nanoparticles in them or those that have already emp-
tied their nanoparticulate contents into the cytoplasm.
To further confirm release of HMSNs from the
endosomes, cells were incubated with FITC-loaded
HMSNs and their intracellular localization was investi-
gated by TEM at 3 h time point. The results as shown
in Figure 8c demonstrate that HMSNs adhered to the
plasma membrane were subsequently internalized by a
vesicle-mediated endocytosis process. This is evident by
appearance of some cytoplasmic vacuoles harbouring
non-clustered nanoparticles in Figure 8c-d. Additionally,
nanoparticles located outside the endosomes were also
observed as shown in Figure 8d., which is consistent
with the previous result obtained by confocal fluores-
cence microscopy. This further emphasizes the fact that
HMSNs are able to escape the endolysosomal entrap-
ment in just a short period of time after their intracellu-
lar uptake. At all phases of HMSNs interaction with
cells, the particles predominantly maintained their uni-
formity in shape and showed absence of aggregate for-
mation. Therefore, these particles could serve not only
as vehicles for introducing drugs/chemicals into cells,
but are also capable of releasing their cargo into the
cytoplasm. Nonetheless, the detailed mechanism on the
Figure 4 Cumulative release kinetics of FITC from HMSNs in different solutions.
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clearly elucidated and warrants further research works.
3. Conclusions
Hollow mesoporous silica spheres were prepared by a
sol-gel/emulsion (oil-in-water/ethanol) method wherein
hydrated silica gel was formed on the surface of HMSNs.
This surface layer had a mesoporous structure, with a
pore diameter of about 2 nm. FITC adsorption studies
revealed that HMSNs had a high adsorption capacity for
FITC at high concentration of the nanoparticles. Their
release kinetics showed that FITC adsorbed onto these
HMSNs could be released continually over one week in
inorganic solution, whereas a burst release kinetics of the
fluorescent dye was observed just within a few hours in
organic solution. The synthesized nanoparticles also
showed good biocompatibility with Hela cells wherein
they show ability to be released from the endosomal
compartment after intracellular uptake by endocytosis. In
summary, this work demonstrated the potential of produ-
cing HMSNs as a carrier for protein/drug delivery for
imaging and other biomedical applications.
4. Experimental
4.1. Materials
Tetraethyl orthosilicate (TEOS) (A.R.), anhydrous etha-
nol, cetyltrimethylammonium bromide (CTAB) (A.R.)
and ammonia (25%) were purchased from Tianjin
Chemical Corporation (Tianjin, China). Deionized water
was prepared with an ion exchange System
4.2 Synthesis of hollow mesoporous silica spheres
HMSNs were synthesized by the ammonia-catalyzed
hydrolysis and condensation of TEOS in mixed ethanol-
water solvents, with CTAB used as a surfactant. TEOS and
CTAB were first dispersed in 13 mL 95% ethanol and 27.5
mL water. 25% ammonia solution was then added after
diluting it with ethanol, and this was kept stirring at 700
rpm for 3 h. When the reaction was completed, the resul-
tant products were collected by centrifugation and washed
with water. Finally the stable spheres with hollow structure
were obtained by calcinations at 200°C with an increment
rate of 5°C/min for 6 h and then at 600°C for 6 h.
4.3 Characterization of hollow mesoporous silica spheres
Transmission Electron Microscopy (TEM) images were
recorded on a JEOL 2010 transmission electron micro-
scope operated at an acceleration voltage of 200 kV.
Samples for TEM measurements were prepared by dip-
ping a drop of the colloidal solution onto Formvar
coated copper grids. Scanning Electron Microscopy
(SEM) images were taken on a Shimadzu SSX-550 field
emission scanning electron microscope at 15.0 kV. N2
adsorption-desorption isotherm measurements were car-
ried out on a Quantachrome Autosorb-1 pore analyzer
at 77 K under a continuous adsorption condition.
Figure 5 Influence of different concentrations of HMSNs on the cell viability of Hela cells.
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the measurements. Brunauer-Emmett- Teller (BET) ana-
lyses was used to determine the surface areas and pore
sizes of the products.
4.4 Loading of FITC into hollow mesoporous silica
spheres
FITC was used as a model drug and the effect of differ-
ent particle concentration on drug loading was studied.
Different concentrations of HMSNs (1, 5 and 10 mg/
mL) were mixed with 1 mL of 1 mg/mL FITC in acet-
one solution. The mixture was then incubated for differ-
ent time duration at ambient temperature, followed by
centrifugation at 5000 rpm for 5 min. FITC was quanti-
fied, using a UV-vis spectrophotometer, according to its
absorbance peak at 488 nm. Raw data were converted to
concentration (μg/mg) of FITC using the standard
curves obtained at different time point.
4.5 Release profiles of FITC from hollow mesoporous
silica spheres
The FITC-loaded HMSNs, obtained as described in sec-
tion 2.4, were mixed with 1 mL of RPMI 1640 medium
(pH 7.4), acetone or PBS (pH 5.2) and left incubated at
ambient temperature under gentle shaking. A 100 μL
aliquot of supernatant was removed at a given time after
centrifugation at 5000 rpm for 5 min and this was sup-
plemented with 100 μL of fresh PBS, acetone or RPMI
1640 medium, respectively. The absorbance of FITC at
488 nm was recorded, and the cumulative release of
FITC was calculated. One-way ANOVA and Duncan’s
multiple-range test for post hoc comparisons were car-
ried out, and a = 0.05 significant level was used.
4.6 In vitro cellular viability tests
Hela cells were cultured in RPMI-1640 medium (Gibco,
Life Technologies, Vienna,Austria) supplemented with
10% fetal bovine serum (Gibco, Life Technologies,
Vienna, Austria), 100 U/mL penicillin and 0.1 mg/mL
streptomycin (Geneticin, GibcoBRL life Technology,
Inc). Cells were maintained at 37 °C in a humidified 5%
CO2atmosphere. For MTS assay, Hela cells were col-
lected and diluted to a density of 1×10
5 cells/mL in
complete medium, and then seeded onto 96-well plates
(100 μL/well). After an overnight culture of 24 h, nano-
particles of different concentrations(50,100, 200, 500,
Figure 6 Uptake of HMSNs into Hela cells at different time points.
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then incubated for another 24 or 48 h at 37 °C. Its viabi-
lity was assessed using the Cell Titer 96 aqueous one
solution assay (Promega, Madison, WI). The reagent
contains tetrazolium compound [3-(4,5-dimethylthiazol-
2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetra zolium, inner sath; MTS]. The relative cell viability
(%) related to control wells containing cell culture med-
ium without nanocrystals was calculated by [A]expt/[A]
control × 100, where [A]expt is the absorbance of the
test sample and [A]control is the absorbance of control
sample.
4.7 Cell imaging
Hela cells were grown on a glass cover slide for 24 h.
The HMSNs (100 μg/mL)
Loaded with FITC were added and the cells were
incubated for varying times (3 and 6 h). The cells were
imaged in bright field and under UV infrared excitation
using a Nikon confocal microscope.
4.8 Intra cellular release study of FITC-loaded
nanoparticles
Hela cells were grown overnight on glass-bottom culture
dishes (MattekTM), and then incubated with culture
medium containing 100 μg/mL of FITC-loaded HMSNs
for 3 h at 37°C. Release of FITC-loaded nanoparticles
from the endosomes were imaged by staining the endo-
somes with a rabbit polyclonal antibody to EEA1 (early
endosome marker, Molecular Probe) and visualized with
Alexa Fluor 568 goat anti-rabbit secondary antibody
(Molecular Probe). The stained cells were then imaged
using a Zeiss LSM 510 laser-scanning microscope
(Thornwood, New York). Images were captured using
the Evolution MP Cooled Camera Kit (Corporate Head-
q u a r t e r s ,M D ,U S A ) .T oa c q u i r eT E Mi m a g e so ft h e
cells, they were fixed with 2.5% glutaraldehyde (Electron
Microscopy Sciences) in 0.1 M sodium cacodylate
(Ted PellaTM) buffer (pH 7.3) for 20 min at room tem-
perature. This was followed by washing with 0.1% caco-
dylate buffer, and postfixing with 1% osmium tetroxide
Figure 7 Cellular release of FITC-loaded HMSNs from endosomes in Hela cells.( a )F I T C - l o a d e dH M S N s ;( b )e n d o s o m e s ;( c )b r i g h tf i e l d
image; (d) merge.
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Page 8 of 10(Electron Microscopy Sciences) solution for 30 min.
Subsequently, the cells were counterstained with 4%
uranyl acetate (Electron Microscopy Sciences) for 30
min, washed with distilled water, dehydrated in 100%
ethanol, and embedded in DurcupanTM ACM resin
(FlukaTM).
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